PRESS RELEASES
19-Jun-2008Le "Prix Debiopharm/Valais pour les Sciences de la Vie" honore un chimiste valaisan pour son procédé électrochimique novateur
15-May-2008
Debiopharm Signs License Agreement for Marketing of Salvacyl®/Moapar 3-month for Sexual Deviations
28-Apr-2008
Clinical Update – Debio 025 in Hepatitis C - Presentation of Phase IIa Efficacy Results
14-Apr-2008
Debiopharm and Airmid Sign Option and License Agreement for the Development of Debio 0824, an ShK Peptide for Autoimmune Disorders
02-Apr-2008
Clinical Update – Debio 0614 (istaroxime) in Acute Heart Failure
|
|